Asensus Surgical Inc (ASXC)

$0.66 0.03 (5.58%)

16:10 EDT ASXC Stock Quote Delayed 30 Minutes

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday

By William White, InvestorPlace Writer Sep 26, 2022

Good morning, investor! We're starting off the week with a breakdown of the biggest pre-market stock movers for Monday morning!

7 Penny Stocks to Pick Up if You Have $100 to Spare

Asensus Is a Bet on the Push to Reduce Robotic Surgery Costs

7 Penny Stocks That Could Be the Next Big Thing

Volume:

Previous Close -

Market Cap 157.45M

PE Ratio -9.40

EPS -0.07

Volume (Avg. Vol.) 803,261

Day's Range $0.60 - $0.66

52-Week Range $0.28 - $1.18

Dividend & Yield N/A (N/A)

ASXC Stock Predictions, Articles, and Asensus Surgical Inc News

From InvestorPlace
From the Web

If You’re Buying The Asensus Surgical Stock Rebound, Watch Out

By Thomas Niel, InvestorPlace Contributor Jun 21, 2021

For those looking for short-term trades, this could still end up being a profitable opportunity. But, considering its history of disappointments, don't be surprised if sentiment for ASXC stock once again turns on a dime.

Asensus Surgical Stock Is Coiling for the Next Move Higher

By Louis Navellier and the InvestorPlace Research Staff Jun 8, 2021

As Asensus pioneers a new standard of digitally enhanced surgery, ASXC stock holders should stay patient and hold on for the long term.

Asensus Surgical Investors Need To Take Long-Term View on Its Technology

By Dana Blankenhorn, InvestorPlace Contributor May 31, 2021

Asensus claims its Senhance can do a hysterectomy for half what Intuitive's DaVinci robot costs, with renewable instruments and haptic feedback. The long haul is the only way to play ASXC stock.

ASXC Stock: Why Popular Play Asensus Surgical Is Climbing Today

By Robert Lakin, InvestorPlace Contributor May 26, 2021

ASXC stock got an analyst 'buy' rating just days after reporting positive Q1 results. Asensus Surgical remains a worthy investment.

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday

By William White, InvestorPlace Writer May 26, 2021

Good morning, investors! Join us as we kick off the day with a look at the biggest pre-market stock movers for Wednesday.

Hold Asensus Surgical Stock as Next-Gen Senhance System Gains Traction

By Louis Navellier and the InvestorPlace Research Staff May 18, 2021

ASXC stock holders should appreciate the company's ambitious vision as Asensus introduces its innovative surgical tech into multiple regions.

Asensus Surgical Is a Great Investment, but Not Much of a Retail Trade

By Faizan Farooque, InvestorPlace Contributor May 3, 2021

ASXC stock is an interesting play in the digital surgery space, especially with surgery numbers expected to pick up in the coming months.

ASXC Stock: Why Penny Stocks Play Asensus Surgical Is Soaring Today

By Chris MacDonald, InvestorPlace Contributor Apr 21, 2021

Today, investors in ASXC stock are seeing some very nice gains as optimism grows in the surgical sector coming out of this pandemic.

9 Reddit Penny Stocks That Are Running Out of Gas

By Thomas Niel, InvestorPlace Contributor Apr 13, 2021

Once flying high on their status as Reddit stocks, these nine penny stocks are falling back towards prior price levels.

Asensus Surgical Can’t Support This Valuation and Won’t Anytime Soon

By Vince Martin, InvestorPlace Contributor Apr 4, 2021

ASXC stock rode the Reddit rally up. Now the business has to deliver — but there's simply not enough evidence to bet on that happening.

Investing in Asensus Surgical Requires the Patience of a Surgeon

By Chris Markoch, InvestorPlace Contributor Apr 1, 2021

ASXC stock is extremely overvalued. And that means that investors may be waiting a long time for the stock to meet its lofty expectations.

Investors Should Pass On Unreliable Asensus Surgical

By Joel Baglole, InvestorPlace Contributor Mar 30, 2021

ASXC stock has been pushed higher by retail investors on Reddit. If it weren't for those investors, the stock would be trading under $1.

Despite Name Change, Asensus Stock Is Still One to Avoid

By InvestorPlace Research Staff Mar 26, 2021

With the jury still out whether its Sehance digital-surgery system is finally ready for primetime, there's no use buying into ASXC stock at today's inflated price.

In a Time of Transition, Asensus Surgical Stock Remains a Worthy Investment

By David Moadel, InvestorPlace Contributor Mar 26, 2021

Before you consider investing in ASXC stock, you'll definitely want to be aware of the important changes going on in the stock and company.

Transenterix Stock Has More Problems Than a Simple Name Change Can Fix

By Josh Enomoto, InvestorPlace Contributor Mar 23, 2021

TRXC stock has undergone a name change but that doesn’t change the nature of the investment, for better or for worse.

A Name Change Won’t Fix the Disaster That Is Asensus Surgical

By Ian Bezek, InvestorPlace Contributor Mar 10, 2021

TransEnterix is now Asensus Surgical. However, this is unlikely to improve sales for Asensus' floundering line of products. Thus, fade the pop in ASXC stock.